MedTrace Logo

Contribution of a Clinical Pathway for the Treatment of Hip Prosthesis Infections

NCT02660268 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 164

Last updated 2024-05-31

No results posted yet for this study

Summary

The main objective is to determine the contribution of a clinical pathway to improve the effectiveness of medico-surgical management of hip prosthesis infections in terms of clinical cure. The hypothesis raised is that the implementation of a clinical pathway would improve the performance of the medical and surgical management of chronic infections of prosthetic hip.

Conditions

  • Hip Prosthesis Infection

Interventions

OTHER

Clinical Pathway

Implementation of a Clinical Pathway for Medical and Surgical Management of Hip Prosthesis Infections

Sponsors & Collaborators

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Patricia PAVESE, MD · University Hospital, Grenoble

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-21
Primary Completion
2024-02-07
Completion
2024-02-07

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02660268 on ClinicalTrials.gov